Mindset Pharma (CSE:MSET) files a sixth U.S. provisional patent

" Optimi Health (CSE:OPTI) engages U.S. based law firm for patent support

Optimi Health Corp. (OPTI) is working with Thomas Finetti, partner at Charney IP Law, to oversee ongoing patent activities.
Entheon Biomedical - CEO, Timothy Ko. - The Market Herald Canada

" Entheon Biomedical (CSE:ENBI) subsidiary partners with 3W Wellness

Entheon Biomedical (ENBI) subsidiary, HaluGen Life Sciences, has partnered with 3W Wellness to drive brand awareness.
Red Light Holland - Director and CEO, Todd Shapiro (Right) - The Market Herald Canada

" Red Light Holland (CSE:TRIP) partnering with fresh and dried mushroom producers

Red Light Holland (TRIP) has entered a non-binding letter of intent to acquire a 51-per-cent stake in Acadian Exotic Mushrooms Ltd.
Pharmadrug to acquire psychedelics company

" Core One (CSE:COOL) subsidiary developing psychedelic drug formulation AKO001

Core One Labs (COOL) subsidiary Akome Biotech Ltd. is developing a psychedelic drug formulation to reduce neurological damage resulting from ischemic strokes.
PharmaDrug (CSE:BUZZ) launches online psilocybin retail platform in the Netherlands

" The Good Shroom Co Inc. (TSXV:MUSH) begins sales of the Velada Cannabis and Functional Mushroom product line

The Good Shroom Co’s (MUSH) wholly-owned subsidiary, Teonan Biomedical has received authorization to begin selling its cannabis-infused beverages.
Red Light Holland (CSE:TRIP) merges with Creso Pharma

" Red Light Holland (CSE:TRIP) merges with Creso Pharma

Red Light Holland (TRIP) has merged with Creso Pharma to form The HighBrid Lab, a global psychedelics and cannabis company.
Core One Labs (CSE:COOL) plans share consolidation in preparation for Nasdaq listing

" Core One Labs (CSE:COOL) plans share consolidation in preparation for Nasdaq listing

In preparation for a potential listing of its common shares on Nasdaq, Core One Labs (COOL) is planning a share consolidation.
Canbud (CSE:CBDX) partners with Molecular Science to research and import psychedelics

" Optimi Health (CSE:OPTI) completes pre-clinical trial application meeting

Optimi Health Corp. (OPTI) has received Health Canada approval to proceed with a formal submission to initiate their previously proposed phase 1 study.
Core One Labs (CSE:COOL) subsidiary patenting biosynthesized psilocybin

" Core One Labs (CSE:COOL) subsidiary patenting biosynthesized psilocybin

Core One Labs (COOL) subsidiary Vocan Biotechnologies is finalizing its provisional patent application for biosynthetic psilocybin production.
Psyched Wellness (CSE:PSYC) to present at the H.C. Wainwright Conference

" Psyched Wellness (CSE:PSYC) to present at the H.C. Wainwright Conference

Psyched Wellness (PSYC) will be participating in the upcoming H.C. Wainwright’s Psychiatry and Beyond Virtual Conference on Thursday, June 17 2021.